Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS)
F1000Research · 2024
DOI: 10.12688/f1000research.138436.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Mariam Kekenadze und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tbilisi State Medical University, Tbilisi, 0141, Georgia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, C9orf72 Protein, DNA Repeat Expansion, Proteins. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome, Medical Research Council.
Abstract (Originalsprache)
Background
Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disorder that affects the upper and lower motor neurons. Several genetic risk factors have been identified in the past decade with a hexanucleotide repeat expansion in the C9orf72 gene being the most significant. However, the presence of C9orf72 repeat expansion has not been examined in the Transcaucasian region, therefore we aimed to analyse its frequency in Georgian patients with ALS.
Methods
We included 64 self-reported Georgian patients with ALS from different parts of the country, fulfilling the Gold Coast criteria. To investigate the presence of an expanded GGGGCC hexanucleotide repeat in the non-coding region of the C9orf72 gene, we performed Repeat-Primed PCR (RP-PCR).
Results
In total, 62 sporadic and two familial ALS cases were identified. Patients were aged 26 to 84 years with a mean age of 58.3 years at disease onset. Bulbar onset was observed in 21.88%, upper limb onset in 34.38%, and lower limb onset in 43.75% of the patients. Frontotemporal dementia (FTD) fulfilling the Strong criteria was diagnosed in seven patients (10.94%). C9orf72 repeat expansion was detected in only one case using RP-PCR; the patient had a family history of dementia.
Conclusions
Our results indicate that C9orf72 hexanucleotide expansion does not belong to the major genetic risk factor of ALS in Georgian patients. Further genetic studies in a bigger study population are needed to reveal the genetic causes of ALS in the Transcaucasian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tbilisi State Medical University, Tbilisi, 0141, Georgia.
- Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, England, UK.
- Department of Neurology, University Hospital Basel, University of Basel, Basel, Basel-Stadt, Switzerland.
- Tbilisi State University, Tbilisi, Georgia.
- Batumi Shota Rustaveli State University, Batumi, Georgia.
ORCID-Profile: Mariam Kekenadze, Henry Houlden
Förderung
- Wellcome Trust
- Wellcome
- Medical Research Council
- Synaptopathies Strategic Award
Zitieren
APA
Kekenadze, M., Rocca, C., Turchetti, V., Nagy, S., Kvirkvelia, N., Vashadze, S., Kvaratskhelia, E., Beridze, M., Kaiyrzhanov, R., & Houlden, H. (2024). Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS). F1000Research. https://doi.org/10.12688/f1000research.138436.2
Vancouver
Kekenadze M, Rocca C, Turchetti V, Nagy S, Kvirkvelia N, Vashadze S, et al. Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS). F1000Research. 2024. doi:10.12688/f1000research.138436.2
BibTeX
@article{Kekenadze2024,
author = {Kekenadze, Mariam and Rocca, Clarissa and Turchetti, Valentina and Nagy, Sara and Kvirkvelia, Nana and Vashadze, Shorena and Kvaratskhelia, Eka and Beridze, Maia and Kaiyrzhanov, Rauan and Houlden, Henry},
title = {Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS)},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.138436.2}
}
EUVIMED